✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Alphamab Oncology

Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
420
Ticker
9966
Exchange
Hong Kong Exchanges and Clearing Limited
Description
Alphamab Oncology is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative cancer therapies. Focusing on the Chinese and global mark...

Alphamab Oncology's Revenues Data

Explore Alphamab Oncology's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric20242023
Total Revenue(USD)
87,705,427a
30,782,891a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Alphamab Oncology’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Alphamab Oncology's Annual Report 2024